Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 22Breast Neoplasms 21Polycystic Ovary Syndrome 12Carcinoma, Non-Small-Cell Lung 11Colorectal Neoplasms 10Lung Neoplasms 8Endometrial Neoplasms 7Pancreatic Neoplasms 6Neoplasms 6Glioblastoma 5Rectal Neoplasms 4Melanoma 4Lymphoma, Large B-Cell, Diffuse 4Insulin Resistance 4Adenocarcinoma of Lung 4Adenocarcinoma 4Uterine Cervical Neoplasms 3Leukoplakia, Oral 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Obesity 2Neoplasm Metastasis 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Hyperandrogenism 2Esophageal Neoplasms 2Erythroplasia 2Endometrial Hyperplasia 2Diabetes Mellitus 2Colonic Neoplasms 2

Interventions

Gemcitabine 12Mitomycin 6Docetaxel 4Radiotherapy 3BCG Vaccine 3tislelizumab 2erdafitinib 2dodecyl maltoside 2disitamab vedotin 2toripalimab 1pemigatinib 1pembrolizumab 1monalizumab 1linrodostat 1enzalutamide 1durvalumab 1bicalutamide 1avelumab 1Watchful Waiting 1Sugars 1Postoperative Period 1Pentosan Sulfuric Polyester 1Nonsteroidal Anti-Androgens 1Nivolumab 1Metformin 1Imiquimod 1Hyaluronic Acid 1High-Intensity Interval Training 1Gels 1Epirubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Non-Muscle Invasive Bladder Neoplasms × Metformin × Clear all
NCT03379909 2023-09-21

TROJAN

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2 Recruiting
49 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡